Volume 30, Number 11—November 2024
Synopsis
Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019
Table 5
Groups |
Mortality rate (95% CI) |
Standardized mortality ratio (95% CI) |
---|---|---|
Overall TB cohort† | ||
Crude mortality rate | 12.69 (11.12–14.43) | Referent |
Mortality rate adjusted for age and sex | 9.77 (8.29–11.43) | 0.91 (0.75–1.07) |
Mortality rate adjusted for age only |
10.50 (9.09–12.07) |
0.98 (0.84–1.12) |
Culture confirmed and treatment completed‡ | ||
Crude mortality rate | 14.19 (12.20–16.41) | Referent |
Mortality rate adjusted for age and sex |
10.92 (9.08–13.03) |
1.02 (0.84–1.20) |
Non-Hispanic White and Black persons§ | ||
Crude mortality rate | 22.84 (19.79–26.23) | Referent |
Mortality rate adjusted for age and race |
19.73 (15.64–24.56) |
1.82 (1.60–2.04)¶ |
US-born persons only# | ||
Crude mortality rate | 22.51(19.50–25.84) | Referent |
Mortality rate adjusted for age and sex | 16.93 (14.10–20.15) | 1.58 (1.41–1.76) |
*All rates are per 1,000 person-years. Georgia population had 900,874 deaths; person-time = 90,796,252 person-years. SMR, standardized mortality ratio; TB, tuberculosis. †Number of patients in TB cohort was 3,182. Overall TB cohort follow-up time was 18,426 person-years (no. deaths = 233). ‡Total number was 2,248. Culture-confirmed TB follow-up time was 12,820 person-years (no. deaths = 182). §Total number was 1,899. Follow-up time was 10,797 person-years (no. deaths = 201). ¶Compared with non-Hispanic White and non-Hispanic Black persons in Georgia. #Total number was 1,557. Follow-up time was 8,929 person-years (no. deaths = 201).
1Current affiliation: University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Page created: September 12, 2024
Page updated: October 22, 2024
Page reviewed: October 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.